ProMIS Neurosciences Inc. Company Profile
NASDAQ: PMNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ProMIS Neurosciences at a glance
ProMIS Neurosciences Inc. (NASDAQ: PMN) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Toronto, ON, Canada. ProMIS Neurosciences is led by Mr. Neil K. Warma M.B.A. and employs about 10 people. At a market capitalization of $28.9 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001374339, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does ProMIS Neurosciences do?
ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS, which enables drug discovery through a combination of protein biology, physics, and supercomputing. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers for treating Alzheimer's disease; PMN267 for the treatment of amyotrophic lateral sclerosis; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils for treating multiple system atrophy. The company also develops PNM440, an alpha-synuclein vaccine for treating multiple synucleinopathies; and PMN311, an amyloid-beta vaccine for the treatment of Alzheimer's. In addition, it is developing therapies for frontotemporal lobar degeneration, Huntington's disease, progressive supranuclear palsy, corticobasal degeneration, and schizophrenia. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. is headquartered in Toronto, Canada.
Business description based on the company's public filings.
Company information
- Legal name
- ProMIS Neurosciences Inc.
- Ticker
- NASDAQ: PMN
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Neil K. Warma M.B.A.
- Employees
- 10
- Headquarters
- 1920 Yonge Street, Toronto, ON, Canada
- Phone
- 416 847 6898
- Website
- promisneurosciences.com
- Market cap
- $28.88M
- SEC CIK
- 0001374339
- Latest annual report
- 10-K · Mar 25, 2026
Companies similar to ProMIS Neurosciences
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| AYTUAytu BioPharma Inc. | 2.66 | 0.00% | $28.91M | vs PMN |
| ATHEAlterity Therapeutics Limited ADR | 1.52 | -8.16% | $29.02M | vs PMN |
| RNTXRein Therapeutics Inc. | 0.3369 | -8.38% | $29.06M | vs PMN |
| NNVCNanoViricides Inc. | 1.14 | -2.56% | $29.13M | vs PMN |
| NXTCNextCure Inc. | 6.45 | -4.87% | $29.53M | vs PMN |
| SERSerina Therapeutics Inc. | 1.12 | -6.67% | $29.76M | vs PMN |
| EDSAEdesa Biotech Inc. | 2.00 | -8.05% | $27.02M | vs PMN |
| NSRXNasus Pharma Ltd. | 2.29 | -10.20% | $26.82M | vs PMN |